關於友邦香港及澳門
友邦香港及澳門友邦保險是友邦保險集團附屬公司，友邦保險集團於 1931 年開始經營香港的業 務。我們於香港及澳門擁有接近 12,000 名財務策劃顧問*，加上獨立理財顧問、經紀和銀行保險 網絡，為逾 180 萬客戶*提供不同類型的產品，包括個人壽險、團體人壽、意外、醫療、個人財物 保險及多款投資選擇的投資連繫壽險計劃。我們亦專注為高端客戶之特有財務需要設計超卓產品 方案。
* 截至 2016 年 2 月

友邦保險簡介
友邦保險控股有限公司及其附屬公司（統稱「友邦保險」或「本集團」）是最大的泛亞地區獨立上 市人壽保險集團，覆蓋亞太區內 18 個市場，包括在香港、泰國、新加坡、馬來西亞、中國、韓國 、菲律賓、澳洲、印尼、台灣、越南、新西蘭、澳門和汶萊擁有全資的分公司及附屬公司、斯里 蘭卡附屬公司的 97%權益、印度合資公司的 49%權益，以及在緬甸和柬埔寨的代表處。

友邦保險今日的業務成就可追溯近一世紀前於上海的發源地。按壽險保費計算，集團在亞太地區 （日本除外）領先同業，並於大部分市場穩佔領導地位。截至 2015 年 11 月 30 日，集團總資產 值為 1,680 億美元。

友邦保險提供一系列的產品及服務，涵蓋壽險、意外及醫療保險和儲蓄計劃，以滿足個人客戶在 長期儲蓄及保障方面的需要。此外，本集團亦為企業客戶提供僱員福利、信貸保險和退休保障服 務。集團透過遍佈亞太區的龐大專屬代理、夥伴及員工網絡，為超過 2,900 萬份個人保單的持有 人及逾 1,600 萬名團體保險計劃的參與成員提供服務。

友邦保險控股有限公司於香港聯合交易所有限公司主板上市（股份代號為「1299」）；其美國預託 證券（一級）於場外交易市場進行買賣（交易編號為「AAGIY」）。

About Medix Medical Services
Medix is a global company specializing in quality global medical management. With constant scientific development expanding different treatment alternatives and medical technologies, Medix serves as a mediator between its clients and the constantly shifting world of medicine, enabling them to take full advantage of the advances it has to offer. Medix supports is customer base of over 1.5 million people, by leveraging on Medix' 300 in-house specialists, on its global quality accredited network comprised of over 3,000 specialists and 1,500 leading medical centers; Medix provides its patients with access to the best possible care in over 90 countries, 24hours a day, 7 days a week, in over 20 languages, including Cantonese and Mandarin. Medix is also proud to share that over the last years it has provided its global customers with proven better medical outcomes: in 20% of the cases Medix has changed the diagnosis and in 43% of the cases Medix recommended a different and optimal treatment plan and prevented unnecessary medical consultations and procedures in 55% of the cases (yearly averages).

Further, Medix is also involved in supporting government related entities and insurers in developing their healthcare strategies and health care reforms, including implementation of medical governance & clinical quality strategies. Believing that accessibility and sustainability of quality care are one of the most important components in fundamental social rights, Medix is very passionate about these issues and is fully dedicated to these activities. In addition to its activities, Medix engages in Charity and funds various public medical research and clinical programs with the aim to support people in obtaining diagnoses and treatments for rare and complex medical conditions.

Last but not least, with the view that digital health will continue to impact and disrupt the way health care is provided and consumed, the Medix Group has decided to launch a Venture Capital Fund, Medix Ventures, with a strong focus on Asia Pacific, aiming to innovate and capitalize on the opportunities within the digital health space. This will enable disruptive digital health solutions to be embedded into the global Medix medical platform servicing customers globally.